Psoriasis light therapy trial pulled before it began
NCT ID NCT03507946
First seen Jun 24, 2026 · Last updated Jun 26, 2026 · Updated 2 times
Summary
This study aimed to test a new LED light device for treating mild to moderate plaque psoriasis. Participants would have treated one plaque at home with the device for 15 minutes daily, five days a week for 12 weeks, while leaving another plaque untreated for comparison. However, the trial was withdrawn before enrolling any volunteers, so no results are available.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
LED light device (460nm, 633nm, 830nm)
What this could lead to
If it had worked, this could point toward a convenient at-home light therapy for easing psoriasis plaques.
What could go wrong
The trial was withdrawn before any participants were enrolled, so no results are available. It is unclear if the device would have been effective or safe.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PSORIASIS VULGARIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.